Trans-1,1,1,4,4,4-hexafluoro-2-butene (HFO-1336mzz-E) (2018)

Abstract

Trans-1,1,1,4,4,4-hexafluoro-2-butene (HFO-133mzz-E) is an odorless gas that finds uses as a foam transfer agent, heat transfer fluid, and specialty gas. The acute 4-h LC₅₀ (in rats) for HFO-133mzz-E is > 17,000 ppm; it was not an eye or dermal irritant in 3- and 13-week repeated-dose inhalation studies in rats at concentrations up to 1.5% (15,000 ppm). HFO-133mzz-E was not a cardiac sensitizer at 70,000 ppm in a standard epinephrine challenge study in Beagle dogs. In a 3-week, repeated-dose (non-GLP) inhalation range-finding study in male and female rats, HFO-133mzz-E concentrations of 7500 and 15,000 ppm were determined to be well-tolerated. In the follow-up, GLP-compliant, 28-day repeated-dose inhalation study (as per OECD 412), male and female rats were exposed to 0, 1000, 10,000, or 15,000/20,000 ppm (20,000 ppm concentration was decreased to 15,000 ppm after week 1 because of deaths and body weight loss). The study no-observed-adverse-effect level (NOAEL) was established at 10,000 ppm based on reduced body weight gain and mortality observed at 15,000 ppm. In a 90-day GLP-compliant repeated-dose study (as per OECD 413), male and female rats were exposed to 0, 1000, 5000, 7500, or 15,000 ppm HFO-133mzz-E. Three male rats exposed to 15,000 ppm HFO-133mzz-E died during exposure; clinical signs such as restlessness, blepharospasm, and myoclonic jerks were also observed, during the first month of the study, at 15,000 ppm. There were no significant gross or histopathological organ/tissue lesions attributable to HFO-133mzz-E exposure. The study NOAEL was established at 7500 ppm. In a GLP prenatal developmental study (OECD 414), groups of time-mated nulliparous female rats were exposed via inhalation to 0, 1000, 5000, 7500, or 15,000 ppm HFO-1336mzz-E beginning on gestation day (GD) 6 up to and including GD 19. Under the conditions of this study, the NOAEL for maternal and fetal effects was established at 7500 ppm. HFO-1336mzz-E was not genotoxic in either in vitro or in vivo assays. Based on the results of the 90-day inhalation study, 7500 ppm was determined to be the NOAEL and was selected as the point of departure for the derivation of the 8-h time-weighted average (TWA), health-based workplace environmental exposure level (WEEL) value. This subchronic inhalation NOAEL was adjusted to account for duration of exposure, interindividual variability, and intraindividual variability. The resulting 8-h TWA WEEL value of 400 ppm is fully expected to provide a significant margin of safety against the production of any potential adverse health effects in workers following long-term inhalation exposure to HFO-1336mzz-E.

Keywords

Trans-1,1,1,4,4,4-hexafluoro-2-butene workplace environmental exposure level occupational exposure level time-weighted average

Get full access to this article

View all access options for this article.

References

Ahrens

(2015) Water Solubility of Gases. Report No. 20150021.01. Frankfurt: Siemens AG.

Atterson

(2010) Acute cardiac sensitization study of KCD-9629 in Beagle dogs. Study No. WIL-189224. Report No. DuPont-17743-1522. WIL Research A Charles River Co., Ashland, OH. Unpublished report for E.I. du Pont de Nemours and Company and DuPont Haskel, Newark, DE February.

Chemours (2016) CD-59 Foam Expansion Agent Safety Data Sheet. Version 4.1. Wilmington: The Chemours Company FC, LLC.

DuPont (2010a) H-29503. Bacterial reverse mutation assay using gas-phase exposure. No. DuPont-17743-501. Charles River Laboratories Preclinical Services Montreal. Unpublished report for E.I.du Pont de Nemours and Company, Wilmington, DE June.

DuPont (2010b) H-29503. In Vitro mammalian Chromosome Aberration Test using gas-phase exposure. Report No. DuPont-17743-546. Charles River Laboratories Preclinical Services Montreal. Unpublished report for E.I. du Pont de Nemours and Company, Wilmington, DE June.

Fraser

(2013) Flammability determination of HFO-1336mzz-E (trans-1,1,1,4,4,4-Hexafluoro-2-butene) using ASTM E-681-04 and ASHRAE Standard 34. Wilmington: DuPont Fluoroproducts, Chestnut Run Laboratories.

Kao

(2007a) Summary of HFO-1336mzz-E (trans-1,1,1,4,4,4-Hexafluoro-2-butene) boiling point determination (Report No. 1336-2E). Wilmington: DuPont Fluoroproducts, Chestnut Run Laboratories.

Kao

(2007b) Summary of HFO-1336mzz-E (trans-1,1,1,4,4,4-Hexafluoro-2-butene) density determination (Report No. 1336-3E). DuPont Fluoroproducts, Chestnut Run Laboratories, Wilmington, DE March.

Kao

(2007c) Summary of HFO-1336mzz-E (trans-1,1,1,4,4,4-Hexafluoro-2-butene) vapor pressure determination per OECD Test No. 104 (Report No. 1336-1E). DuPont Fluoroproducts, Chestnut Run Laboratories, Wilmington, DE March.

10.

Kegelman

(2009) H-28542: One-hour inhalation approximate lethal concentration (ALC) in male rats. Report No. DuPont-26135. E.I. du Pont de Nemours and Company, DuPont Haskell Global Centers for Health & Environmental Sciences, Wilmington, DE February.

11.

Kegelman

(2011) H-29966. Inhalation toxicity screening in rats. Project ID: DuPont-19179-700. E.I. Wilmington: du Pont de Nemours and Company, DuPont Haskell Global Centers for Health & Environmental Sciences.

12.

Kegelman

(2012) H-29966. Inhalation median lethal concentration (LC50) study in rats. Project ID No. DuPont-19179-721. E.I. Wilmington: du Pont de Nemours and Company, DuPont Haskell Global Centers for Health & Environmental Sciences.

13.

(2010) H-29503. Acute inhalation toxicity study in rats. Report No. DuPont-17743-721. Charles River Laboratories Preclinical Services Montreal. Unpublished report for EI du Pont, Wilmington, DE June.

14.

Randazzo

(2016) A 3-week whole-body inhalation range-finding study of HFO-1336mzz-E in Wistar Hanover rats. Report No. WIL-287501. WIL Research A Charles River Co., Ashland, OH. Unpublished report for The Chemours Company, Wilmington, DE May.

15.

Schuler

(2013) H-30385: 28-Day inhalation toxicity study in the Wistar rat. Study Identification No. DuPont-19179-782. Harlan Laboratories Ltd., Switzerland, Unpublished report for E.I. du Pont de Nemours and Company, Wilmington, DE July.

16.

Sobocinski

Krenzel

(2015) H-31452: Determination of octanol/water partition coefficient (Kow) by high performance liquid chromatography. DuPont-21115-386 RV1. E.I. Wilmington: du Pont de Nemours and Company, DuPont Haskell Global Centers for Health & Environmental Sciences.

17.

Stankowski

(2015) H-31452: In vitro mammalian cell forward gene mutation (CHO/HPRT) assay with duplicate cultures using gaseous exposure. Report No. DuPont-21115-516. BioReliance Corporation, Rockville, MD. Unpublished report for E.I. du Pont de Nemours and Company, Wilmington, DE May.

18.

Theuns-van Vliet

(2016) Inhalation prenatal developmental toxicity study with HFO-1336mzz-E in rats. Report No. V20685. Triskelion A TNO Company, Netherlands. Unpublished report for The Chemours Company, Wilmington, DE July.

19.

van Triel

(2016) Sub-chronic (13-week) inhalation toxicity study with HFO-1336mzz-E in rats. Report No. V20686. Triskelion A TNO Company, Netherlands. Unpublished report for The Chemours Company, Wilmington, DE July.